HOME >> MEDICINE >> NEWS
NHLBI and NIH statements on totally implanted permanent artificial heart

for this device, it can mean longer life and a better quality of life.

Dr. Zerhouni:

For over half a century, scientists and engineers have dreamed of a total artificial heart. The National Heart, Lung, and Blood Institute's long-term commitment to this technology has helped to make this dream a reality. It is a shining example of an NIH institute supporting the development of a medical device that has great public impact from basic research through preclinical testing and on to clinical readiness. The total artificial heart will extend and improve the quality of life for patients who have no other treatment option.

This accomplishment also demonstrates the kind of long term interdisciplinary scientific efforts needed to address increasingly complex health challenges that often seem initially insurmountable to many. This could not have happened without the patient and far sighted leadership of NHLBI and NIH over several decades.


'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
5-Sep-2006


Page: 1 2

Related medicine news :

1. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
2. NHLBI awards 12 Womens Health Initiative contracts
3. NHLBI offers complete guide to physical activity for a healthy heart
4. NHLBI media availability: Low-fat dietary pattern and weight change
5. NHLBI research highlights at American Heart Associations scientific sessions
6. MGH named by NHLBI as Specialized Center for Cell-Based Therapy for Heart, Lung and Blood Diseases
7. New NHLBI-sponsored study shows programs can teach children to eat healthier
8. Miniature implanted devices could treat epilepsy, glaucoma
9. Are one-third of costly implanted heart devices unnecessary? New study suggests yes
10. New implanted contacts designed to fix nearsightedness
11. Test identifies best candidates for implanted cardiac defibrillator, screens out those not helped

Post Your Comments:
(Date:4/21/2015)... 2015 Invictus Medical has secured ... university for a second innovative technology aimed at ... to newborn infants’ cognitive development. , “This technology ... we have identified through extensive interviews and input ... Hutchinson, Invictus Medical’s Chief Technology Officer. “We believe ...
(Date:4/20/2015)... Heritage Woods of Centralia, a Gardant affordable assisted ... Spaghetti Dinner from 4 p.m. to 6 p.m. on ... Centralia, Illinois, houses senior living apartments, affordable assisted living ... older. , Guests are invited to tour the community ... seniors. After the tours, they can take home spaghetti ...
(Date:4/20/2015)... (PRWEB) April 21, 2015 Reality show ... and girlfriends at the twentieth annual Michigan International Women’s ... in Novi. , “There is lots to see and ... to shopping for fashion and gifts,” said Beth Anderson, ... are entertaining and encouraging with appearances from Randy Fenoli ...
(Date:4/20/2015)... The partners of Urgent Care of Westchester and Riverdale ... Med Spa with a special event. Residents of Westchester County ... p.m. on April 24 on 909 Midland Ave. in Yonkers, ... will also get the chance to win free services from ... purchase, as well as up to 40 percent discounts on ...
(Date:4/20/2015)... The American Association for Physician Leadership® ... Improvement as the 2015 winner of the Leape Ahead ... Meeting, April 18, in Las Vegas, Nevada. , ... safety can be dramatically improved,” said Peter Angood, MD, ... Medicine and its Academy for Quality and Safety should ...
Breaking Medicine News(10 mins):Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 3Health News:Bella Diosa Says Hello to Yonkers Community with Spa Party 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 2Health News:2015 Leape Ahead Award honors Northwestern Medicine’s Academy for Quality and Safety Improvement 3
(Date:4/20/2015)... Calif. , April 20, 2015  Published ... positive trends in the ability of Neuraltus ... progression of amyotrophic lateral sclerosis (ALS, also known ... 6-month treatment period. While NP001,s slowing of decline ... study was not statistically significant, clinically meaningful slowing ...
(Date:4/20/2015)... April 20, 2015  OpGen, Inc., a molecular ... of its executive management team with the appointments ... executive Kevin Krenitsky , M.D. as president, ... chief financial officer. With more ... global diagnostic and biotechnology operations, including senior commercial ...
(Date:4/20/2015)... , April 20, 2015 ... disease and specifically autism drug candidates, a few viable ... such as fragile X syndrome.   Biotech Companies in ... (NASDAQ: CYTR ), Trovagene, Inc., (NASDAQ: TROV ... Laboratories (NYSE: ABT ) & Lexicon Pharmaceuticals, Inc. ...
Breaking Medicine Technology:Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 2OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 3OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 4Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 2Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 3Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 4Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 5Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research 6
Cached News: